Background Since the beginning of highly active antiretroviral therapy utilization, the
association of renal impairment with treatment toxicity is more prevalent. Tenofovir disoproxil …

Background Tenofovir (TDF) has been associated with renal function deterioration, but local
data regarding the incidence and risk factors for this adverse event were lacking. Objectives …

Concern exists about the risk of nephrotoxicity using tenofovir (TDF) in HIV-infected patients.
We performed a retrospective case-control study including 122 consecutive TDF-naive …

Introduction With improvements in survival and disease progression in the era of combined
antiretroviral therapy, complications such as kidney disease are becoming increasingly …

Background: Tenofovir (TDF) is preferred nucleoside reverse transcriptase inhibitors (NRTI)
for the treatment of human immunodeficiency virus infection because of its potency and …

Objective To determine the evolution of renal function in highly treatment-experienced
patients with normal renal function at baseline receiving tenofovir disoproxil fumarate (TDF) …

OBJECTIVE: To evaluate the prevalence and incidence of nephrotoxicity in HIV-infected
patients enrolled in the SCOLTA Project tenofovir cohort and to identify possible risk factors …

Objectives and Method: There are growing concerns of tenofovir disoproxil fumarate (TDF)–
associated renal toxicity. We evaluated the effect of long-term TDF exposure on renal …

Importance of the field: Tenofovir (TFV) is a nucleotide analogue widely used for the
treatment of HIV infection. Despite its proven efficacy and safety, cases of kidney tubular …

Objectives Tenofovir disoproxil fumarate (TDF) is a nucleotide reverse transcriptase inhibitor
commonly used in the treatment of HIV infection. This retrospective study aims to establish …